2-tert-butylhydroquinone has been researched along with Respiratory Distress Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, G; Chen, Y; Feng, D; Liu, M; Lv, X; Shi, X; Wei, J; Wu, L; Zhang, P; Zhou, H | 1 |
1 other study(ies) available for 2-tert-butylhydroquinone and Respiratory Distress Syndrome
Article | Year |
---|---|
Nrf2 activation protects against intratracheal LPS induced mouse/murine acute respiratory distress syndrome by regulating macrophage polarization.
Topics: Animals; Cell Line; Cell Polarity; Cytokines; Hydroquinones; Inflammation Mediators; Lipopolysaccharides; Lung Injury; Macrophages; Male; Mice, Inbred C57BL; NF-E2-Related Factor 2; Respiratory Distress Syndrome; Trachea | 2018 |